Viracta Therapeutics Inc (VIRX): big news coming

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Viracta Therapeutics Inc (VIRX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	22
Boards Moderated	0
Alias Born	06/20/2017

Re: None

Monday, 03/01/2021 7:14:16 AM

Monday, March 01, 2021 7:14:16 AM

big news coming

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent VIRX News

Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2025 10:00:32 PM
Viracta Therapeutics Announces Wind Down of Operations • GlobeNewswire Inc. • 02/05/2025 10:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2025 09:30:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2025 10:14:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2025 09:08:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:39:52 PM
Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives • GlobeNewswire Inc. • 12/26/2024 09:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 10:14:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 09:06:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2024 10:20:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 12:30:08 PM
Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/13/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:46:38 PM
Viracta Therapeutics Announces Reprioritization of Resources to Enhance Focus on Nana-val Development Program in Patients with Relapsed or Refractory EBV-Positive Peripheral T-Cell Lymphoma • GlobeNewswire Inc. • 11/06/2024 09:30:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 10:10:04 PM
Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 11:15:25 AM
Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2024 11:05:00 AM
Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan • GlobeNewswire Inc. • 08/14/2024 11:00:00 AM

More VIRX News

InvestorsHub NewsWire

FEATURED MedWellAi, Inc (formerly Integrated Ventures) Completes Corporate Rebranding And Transformation Into Ai-Driven Healthcare and Wellness • Jun 24, 2025 8:45 AM

FEATURED Envirotech (EVTV) Announces Vision for Multi-modal Electric Mobility Ecosystem • Jun 24, 2025 8:42 AM

Avant Technologies Creating New Company for Expansion of Diabetes Program • AVAI • Jun 24, 2025 8:00 AM

From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts • ABX • Jun 23, 2025 8:45 AM

Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM

ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow